CompletedPhase 4

Vision II: Evaluation of GALILEO Intravascular Radiotherapy System

France268 participantsStarted 2002-02

Plain-language summary

To assess the safety and effectiveness of intravascular brachytherapy for the treatment of intrastent restenosis of coronary lesions with the Galileo system

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with angor, patients with only one de novo lesion. Target zone must be \< 52 mm, artery section must be \< 3,7mm and \> 2,25 mm Exclusion Criteria: * Vessel with extremely tortuous proximal segment, lesion with angulous segments (\>90°) Unstable ventricular arrhythmia, dialysis, MI within the last 72 hours etc…

What they're measuring

MACE

Timeframe: 6 months

Trial details

NCT IDNCT00180583

SponsorAbbott Medical Devices

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2005-07

View on ClinicalTrials.gov More Coronary Artery Disease trials